XM does not provide services to residents of the United States of America.

XM does not provide services to residents of the United States of America.
G
G

GlobalPayments

News

Reuters - 2 weeks ago

Hugo Boss says it won't reach 2025 revenue, profit targets; shares slip

UPDATE 3-Hugo Boss says it won't reach 2025 revenue, profit targets; shares slip Recasts to add 2025 targets won't be reached, updates share move in paragraph 2, analyst comment in 6, adds CFO comments throughout By Linda Pasquini and Ozan Ergenay Nov 5 (Reuters) - Hugo Boss' BOSSn.DE on Tuesday reported that its third -quarter operating profit slightly exceeded expectations , but said it wouldn't reach its revenue and profit growth targets for 2025 amid tepid demand, sending shares lower in mor
H
G
Reuters - 3 weeks ago

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Monte dei Paschi di Siena, BHP; updates Volvo Cars, Sabadell Oct 30 (Reuters) - The following bids, mergers, acquisitions, and disposals were reported by 1938 GMT on Wednesday: * * Italy is struggling to find a "strategic" buyer for its stake in lender Monte dei Paschi di Siena BMPS.MI before a year-end deadline, leaving it with little alternative but to turn to the market and broaden a fragmented shareholder base, two sources close to the sale proc
E
A
B
M
G
Reuters - 3 weeks ago

U.S. STOCKS Zimmer Biomet, Shake Shack, Microsoft

BUZZ-U.S. STOCKS ON THE MOVE-Zimmer Biomet, Shake Shack, Microsoft Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes advanced on Wednesday, with the tech-heavy Nasdaq rising to a record high, as investors assessed corporate earnings as well as crucial data showing the economy maintained a steady pace of growth in the third quarter.
A
A
B
C
C
D
E
G
M
M
N
Q
Q
V
A
K
S
U
U
G
W
Z
D
F
O
Reuters - 3 weeks ago

U.S. STOCKS XPO, Blueprint Medicines, AbbVie

BUZZ-U.S. STOCKS ON THE MOVE-XPO, Blueprint Medicines, AbbVie Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were muted on Wednesday as investors assessed mixed corporate results as well as crucial data showing the economy maintained a steady pace of growth in the third quarter.
A
B
C
C
D
E
M
N
Q
Q
V
A
K
S
U
U
G
W
F
O
Reuters - 3 weeks ago

Global Payments Inc reports results for the quarter ended in September 30 - Earnings Summary

Global Payments Inc reports results for the quarter ended in September 30 - Earnings Summary Global Payments Inc GPN.N reported quarterly adjusted earnings of $3.08​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $2.75. The mean expectation of twenty nine analysts for the quarter was for earnings of $3.12 per share.
G
Reuters - 3 weeks ago

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Global Payments, Volvo Cars, CNMC Updates: Oct 30 (Reuters) - The following bids, mergers, acquisitions, and disposals were reported by 1330 GMT on Wednesday: ** Israeli flag carrier El Al Airlines ELAL.TA has withdrawn its bid to buy Israel's largest credit card company, it said, citing its inability to meet requirements by Thursday's deadline.
E
B
G
Reuters - 3 weeks ago

Global Payments sharpens core focus with $1.1 bln medical software unit sale

UPDATE 2-Global Payments sharpens core focus with $1.1 bln medical software unit sale Adds analyst comment in paragraph 3, updates shares in paragraph 2 By Niket Nishant Oct 30 (Reuters) - Global Payments GPN.N will sell its medical software business, AdvancedMD, to investment firm Francisco Partners for $1.13 billion, the companies said on Wednesday, as the financial technology firm slims down to focus on its core operations.
Q
G
Reuters - 3 weeks ago

Global Payments falls after Q3 results miss estimates

BUZZ-Global Payments falls after Q3 results miss estimates ** Shares of Global Payments GPN.N fall ~0.6% to $98.45 premarket ** Payments tech firm reports Q3 adjusted EPS of $3.08 vs expectations of $3.12, according to estimates compiled by LSEG ** Co posts adjusted net revenue of $2.36 bln in the quarter, missing Wall Street expectations $2.38 bln
G
Reuters - 3 weeks ago

Global Payments' third-quarter profit falls on higher expenses

Global Payments' third-quarter profit falls on higher expenses Oct 30 (Reuters) - Global Payments' GPN.N third-quarter profit fell nearly 13% on Wednesday, as higher costs offset gains from the fees it charges merchants for the company's transaction processing technology. The company also said it will sell its medical software unit, AdvancedMD, to technology-focused investment firm Francisco Partners.
G
Reuters - 3 weeks ago

Francisco Partners to buy medical software firm AdvancedMD from Global Payments

Francisco Partners to buy medical software firm AdvancedMD from Global Payments Oct 30 (Reuters) - Technology-focused investment firm Francisco Partners is buying medical software company AdvancedMD from Global Payments GPN.N , the companies said on Wednesday. Financial terms of the deal were not disclosed. Global Payments had acquired AdvancedMD in a $700 million deal in 2018. AdvancedMD, founded in 1999, provides payments and other healthcare-focused services to hospitals and independent physi
G
Reuters - 3 weeks ago

Francisco Partners To Acquire Advancedmd From Global Payments

BRIEF-Francisco Partners To Acquire Advancedmd From Global Payments Oct 30 (Reuters) - Global Payments Inc GPN.N : FRANCISCO PARTNERS TO ACQUIRE ADVANCEDMD FROM GLOBAL PAYMENTS Source text: ID:nBw6XPwpta Further company coverage: GPN.N
G
Reuters - 3 weeks ago

Global Payments Q3 Adjusted EPS USD 3.08 Vs. IBES Estimate USD 3.12

BRIEF-Global Payments Q3 Adjusted EPS USD 3.08 Vs. IBES Estimate USD 3.12 Oct 30 (Reuters) - Global Payments Q3 adjusted revenue USD 2,360 million vs. IBES estimate USD 2,380 million. Q3 EPS USD 1.24 Q3 revenue USD 2,600 million outlook FY adjusted EPS USD 11.54-11.7 outlook FY adjusted revenue USD 9,170-9,300 million
G
Reuters - 3 weeks ago

Alphabet beats and Treasuries rally

MORNING BID AMERICAS-Alphabet beats and Treasuries rally A look at the day ahead in U.S. and global markets from Mike Dolan Markets struggling which way to look will be dizzy again in an event-strewn Wednesday but the spotlight first thing drops on Alphabet's GOOGL.O impressive earnings beat and a relief-rally in election-bruised U.S. Treasuries. A critical fortnight for investors includes next week's U.S.
A
B
B
C
E
G
G
I
M
M
P
U
U
V
V
A
A
K
J
U
U
U
U
G
I
P
Reuters - 3 weeks ago

Global Atomic Provides Update On The Dasa Project

BRIEF-Global Atomic Provides Update On The Dasa Project Oct 29 (Reuters) - Global Atomic Corp GLO.TO : GLOBAL ATOMIC PROVIDES UPDATE ON THE DASA PROJECT Source text: ID:nCNWT2F3pa Further company coverage: GLO.TO
G
Reuters - 3 weeks ago

PayPal's revenue forecast fails to impress as profit push puts growth behind

UPDATE 3-PayPal's revenue forecast fails to impress as profit push puts growth behind Company lifts annual profit forecast as spending holds up Shares fall as weak Q4 revenue forecast hurts sentiment Company moderating growth in Braintree, low-margin businesses Adds executive comment in paragraphs 3 and 6, analyst comment in paragraphs 12 and 19, graphic; Updates shares By Niket Nishant and Manya Saini Oct 29 (Reuters) - PayPal PYPL.O forecast fourth-quarter revenue below estimates on Tuesday as
A
A
G
P
U
G
S
Reuters - 3 weeks ago

PayPal forecasts Q4 revenue below estimates as profit push puts growth behind

PayPal forecasts Q4 revenue below estimates as profit push puts growth behind Company lifts annual profit forecast as spending holds up CEO says "solid progress" on innovation, partnerships Shares have risen 36% so far this year Oct 29 (Reuters) - PayPal PYPL.O forecast fourth-quarter revenue below estimates on Tuesday as the digital payments company focuses more on its higher-margin businesses to boost profitability instead of aggressive expansion.
A
A
G
P
U
G
S
Reuters - 1 month ago

U.S. Autozone, State Street, UnitedHealth

U.S. RESEARCH ROUNDUP-Autozone, State Street, UnitedHealth Oct 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Autozone, State Street and UnitedHealth, on Wednesday. HIGHLIGHTS * Autozone Inc AZO.N : Roth MKM resumes coverage with buy rating; price target $3,634 * Goldman Sachs GS.N : Barclays raises target price to $588 from $565 * ServiceNow Inc NOW.N : Jefferies raises target price to $1,100 from $900 * State St
C
G
S
T
F
G
S
A
Reuters - 2 months ago

U.S. Humana, Portillos, Waters Corp

U.S. RESEARCH ROUNDUP-Humana, Portillos, Waters Corp Oct 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Humana, Portillos and Waters on Tuesday. HIGHLIGHTS * Frontier Communications Parent Inc FYBR.O : TD Cowen cuts to hold from buy * Humana HUM.N : RBC cuts target price to $265 from $400 * Portillos Inc PTLO.O : Stephens cuts to equal-weight from overweight * Waters Corp WAT.N : Jefferies raises to buy from hold
B
C
C
C
H
C
F
G
S
W
C
C
P
Reuters - 2 months ago

U.S. Constellation Brands, Ge Vernova, Republic Services

U.S. RESEARCH ROUNDUP-Constellation Brands, Ge Vernova, Republic Services Oct 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Constellation Brands, Ge Vernova and Republic Services, on Friday. HIGHLIGHTS * Constellation Brands Inc STZ.N : JP Morgan cuts target price to $293 from $307 * Diamondback Energy Inc FANG.O : Gerdes Energy Research cuts to neutral from buy * Ge Vernova GEV.N : HSBC cuts to hold from buy * R
B
P
G
L
R
Reuters - 2 months ago

U.S. Coca-Cola, Estée Lauder, Quanta Services

U.S. RESEARCH ROUNDUP-Coca-Cola, Estée Lauder, Quanta Services Sept 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Coca-Cola, Estée Lauder and Quanta Services on Monday. HIGHLIGHTS * Coca-Cola Co KO.N : JP Morgan raises target price to $78 from $72 * Estée Lauder EL.N : Piper Sandler raises target price to $122 from $114 * Inspire Medical Systems Inc INSP.N : Truist Securities raises PT to $240 from $217 * Low
A
H
M
M
N
S
C
E
G
D
Q

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.